KCHC Annual Review 2023-24 WEB Singles - Flipbook - Page 16
How did we do?
Taking research further
Thanks to our generous donors, we were able to invest £1M in our
pioneering researchers.
Funding groundbreaking clinic trials
Using AI to improve patient outcomes
We awarded £47K towards a large clinical trial
investigating the use of betablockers to slow the
progression of liver cirrhosis. The largest trial of its
kind in the UK, the study will also investigate why
betablockers work for some patients and not others.
The team believe participants will experience a
reduction rate in the progression of their disease and
the trials will also generate a biobank of samples that
can be used to answer important questions about liver
cirrhosis in the future.
Our grant of £62K will help Professor Timothy Jackson
develop a machine-learning system to determine
whether a person has elevated pressure inside their
brain by automatically detecting and interpreting the
rhythmic pulsations at the back of the eye. The project
has the potential to diagnose intracranial pressure
much earlier, improving treatment options and
eliminating the need for invasive tests.
Urology patient Greg McCarthy (L),
pictured with his surgeon,
Mr Kawa Omar (R).
Improving
outcomes for patients
Our funding ensures that King’s
patients and sta昀昀 have access to
the best equipment and facilities.
£12K
towards a new bladder scanner that
will be used across three liver wards
to help reduce patient waiting times
£13K
towards vCreate: a secure video
messaging service that helps minimise
separation anxiety and provide greater
reassurance to neonatal unit parents
£21K
towards two Lifestart trolleys that
enable the mother to be alongside
her baby if resuscitation is needed
before the umbilical cord is clamped
Robot assisted
surgery is paying
dividends
Last year, we invested £1M
towards a state-of-the-art Robot
Assisted Surgical (RAS) system to deliver significant
benefits to patients and staff. With improved surgical
precision and increased patient satisfaction, 236
procedures have been carried out since May 2023.
Compared to the equivalent colorectal and bariatric
laparoscopic surgeries, on average RAS procedures
required 65% less pain relief, length of stay was reduced
by over two days, and the conversion rate to open
surgery was lowered by 95%.
The whole process was so quick and
e昀케cient. As a cancer patient with a
newborn baby, ge琀琀ing up and about
and back to normal family life was
important. In fact my recovery was so
quick that some of my friends didn’t even
know that I’d been in for an operation!”
– Greg McCarthy, robot assisted surgery patient
16
S U P P O R T K I N G S .O R G .U K
